December 7, 2012 – In Canada, it is estimated that 1 in 4 women and 1 in 8 men will develop osteoporosis in their lifetime. This disease weakens the bones, making those affected more vulnerable to fractures. Denosumab, a drug supposed to strengthen the bones, on the contrary, increases the risk of fractures.
